BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9655087)

  • 21. Pancreatic islets activate portal vein endothelial cells in vitro.
    Fontaine MJ; Blanchard J; Rastellini C; Lazda V; Herold KC; Pollak R
    Ann Clin Lab Sci; 2002; 32(4):352-61. PubMed ID: 12458886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of rat colon cancer metastases by perioperative immunostimulation.
    Weese JL; Gilbertson EM; Syrjala SE; Starling JR
    Surgery; 1984 Aug; 96(2):420-6. PubMed ID: 6463870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Augmentation of cytotoxicity of nonparenchymal cell of the liver after continuous IL-2 administration via the portal vein].
    Shimoda K; Oka M; Hazama S; Suzuki M; Lizuka N; Wadamori K; Wang F; Suzuki T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1567-9. PubMed ID: 8373220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon carcinoma cell interaction with liver sinusoidal endothelium inhibits organ-specific antitumor immunity through interleukin-1-induced mannose receptor in mice.
    Arteta B; Lasuen N; Lopategi A; Sveinbjörnsson B; Smedsrød B; Vidal-Vanaclocha F
    Hepatology; 2010 Jun; 51(6):2172-82. PubMed ID: 20513002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: no additional benefit of using retroviral producer cell.
    Iwazawa T; Chau GY; Mori T; Dookeran KA; Rubin JT; Watkins S; Robbins PD; Lotze MT; Tahara H
    Cancer Gene Ther; 2001 Jan; 8(1):17-22. PubMed ID: 11219489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12.
    Xu Q; Guo L; Gu X; Zhang B; Hu X; Zhang J; Chen J; Wang Y; Chen C; Gao B; Kuang Y; Wang S
    Biomaterials; 2012 May; 33(15):3909-18. PubMed ID: 22374455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer.
    Yamaki M; Shinozaki K; Sakaguchi T; Meseck M; Ebert O; Ohdan H; Woo SL
    Int J Mol Med; 2013 Feb; 31(2):299-306. PubMed ID: 23232984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
    Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
    Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen.
    Minami S; Furui J; Kanematsu T
    Cancer Res; 2001 Mar; 61(6):2732-5. PubMed ID: 11289155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
    Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
    Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
    J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation.
    Chen SH; Pham-Nguyen KB; Martinet O; Huang Y; Yang W; Thung SN; Chen L; Mittler R; Woo SL
    Mol Ther; 2000 Jul; 2(1):39-46. PubMed ID: 10899826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.